From overlooking Medicare audit exposure to misjudging revenue quality, these errors can derail your DME acquisition or destroy value post-close.
Find Vetted Medical Equipment Supplier DealsAcquiring a medical equipment supplier offers recession-resistant cash flow and strong demographic tailwinds, but the regulatory complexity of DMEPOS businesses catches many buyers unprepared. These six mistakes consistently surface in lower middle market DME acquisitions.
Market Size
$100B+ total U.S. medical equipment and supplies market; DME/home medical equipment segment estimated at $35B–$45B annually
Growth Trend
Growing
Recession Resistant
Yes
Market Structure
Highly fragmented
Buyers often underestimate audit exposure from historical billing errors, denial rates, or overpayment demands. A single CMS audit post-close can trigger repayment obligations exceeding the acquisition price adjustment.
How to avoid: Commission an independent billing compliance review covering at least three years of claims data, denial rates, and any prior CMS correspondence before signing a letter of intent.
Blended revenue figures obscure whether cash flow is defensible. Episodic equipment sales are far less predictable than rental income or service contracts, yet sellers often present them together.
How to avoid: Require revenue segmentation by type — rental, service contracts, and direct equipment sales — and weight your valuation multiple toward businesses where recurring revenue exceeds 50% of total.
DMEPOS accreditation, Medicare provider numbers, and exclusive distribution agreements are often non-transferable without reapplication, creating dangerous gaps in operational authority post-close.
How to avoid: Verify transferability of every license, accreditation, and supplier contract during due diligence. Build reapplication timelines and interim revenue protection clauses into the purchase agreement.
A business where one hospital system or two referring physician groups drive 40–60% of revenue carries outsized post-acquisition risk, especially if referral relationships are tied to the exiting owner.
How to avoid: Map customer revenue concentration before closing. Require any single customer to represent less than 20–25% of revenue, and negotiate earnouts contingent on key account retention.
Buyers frequently accept inventory at book value without accounting for aging stock, discontinued product lines, or devices superseded by newer technologies, inflating the perceived asset base.
How to avoid: Obtain a third-party inventory aging analysis. Discount or exclude any stock older than 18–24 months and verify that flagship product lines remain actively supported by manufacturers.
Historical EBITDA may not reflect upcoming competitive bidding program adjustments or reimbursement cuts that compress Medicare margins, making trailing financials an unreliable proxy for future performance.
How to avoid: Build a reimbursement sensitivity model using current CMS fee schedules and pending competitive bidding rounds. Stress-test EBITDA at 5–15% reimbursement reductions before finalizing your offer price.
Buyers submit SBA loan applications before independently verifying the Medical Equipment Supplier's normalized EBITDA. When diligence reveals add-backs that don't hold, the deal's debt service coverage collapses and the loan fails underwriting.
How to avoid: Build your EBITDA model with conservative add-back assumptions before engaging an SBA lender. At current rates, a $1M SBA 7(a) loan costs approximately $13,000/month — the Medical Equipment Supplier needs $195,000+ in post-salary EBITDA to clear 1.25x DSCR.
Buyers close on a Medical Equipment Supplier assuming operations transfer smoothly, then discover undocumented processes, informal vendor relationships, and staff who rely on institutional knowledge the seller carries in their head.
How to avoid: Require a 60-day operational documentation period before closing. Walk through every key process with the seller present, document staff responsibilities, vendor contacts, and customer communication protocols. Build a 90-day integration plan before the wire hits.
What experienced buyers verify before committing to a Medical Equipment Supplier acquisition.
The specific concerns and miscalculations buyers face in this industry.
Common miscalculations sellers make that reduce their final price or derail a deal.
Lower middle market DME businesses typically trade at 3.5x–6x EBITDA. Businesses with high recurring rental revenue, clean Medicare compliance, and active DMEPOS accreditation command the upper end of that range.
Yes. SBA 7(a) financing is commonly used for DME acquisitions. Expect to inject 10–20% equity, with sellers often carrying a 5–10% note to bridge valuation gaps and satisfy SBA requirements.
Medicare provider number changes or revalidations typically take 60–180 days. Structure the deal to include interim billing arrangements or escrow provisions protecting revenue during this transition window.
Skipping an independent billing compliance review is the most consequential error. Undisclosed CMS audit exposure or systematic billing errors can generate post-close repayment liability that eliminates acquisition returns entirely.
More Medical Equipment Supplier Guides
DealFlow OS helps you find and evaluate acquisitions with seller signals and due diligence tools. Free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers